- Home
- MDXG vs IOVA Comparison
MDXG vs IOVA Comparison
Compare MDXG & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- IOVA
- Stock Information
- Founded
- MDXG 2006
- IOVA 2007
- Country
- MDXG United States
- IOVA United States
- Employees
- MDXG N/A
- IOVA N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDXG Health Care
- IOVA Health Care
- Exchange
- MDXG Nasdaq
- IOVA Nasdaq
- Market Cap
- MDXG 877.4M
- IOVA 771.4M
- IPO Year
- MDXG N/A
- IOVA N/A
- Fundamental
- Price
- MDXG $6.33
- IOVA $1.93
- Analyst Decision
- MDXG Strong Buy
- IOVA Buy
- Analyst Count
- MDXG 2
- IOVA 10
- Target Price
- MDXG $11.50
- IOVA $12.22
- AVG Volume (30 Days)
- MDXG 842.0K
- IOVA 12.1M
- Earning Date
- MDXG 07-30-2025
- IOVA 08-07-2025
- Dividend Yield
- MDXG N/A
- IOVA N/A
- EPS Growth
- MDXG N/A
- IOVA N/A
- EPS
- MDXG 0.27
- IOVA N/A
- Revenue
- MDXG $352,375,000.00
- IOVA $212,679,000.00
- Revenue This Year
- MDXG $9.55
- IOVA $86.62
- Revenue Next Year
- MDXG $11.43
- IOVA $69.95
- P/E Ratio
- MDXG $23.26
- IOVA N/A
- Revenue Growth
- MDXG 5.34
- IOVA 11070.12
- 52 Week Low
- MDXG $5.47
- IOVA $1.64
- 52 Week High
- MDXG $10.14
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- MDXG 47.21
- IOVA 43.71
- Support Level
- MDXG $6.57
- IOVA $1.85
- Resistance Level
- MDXG $6.85
- IOVA $2.15
- Average True Range (ATR)
- MDXG 0.29
- IOVA 0.12
- MACD
- MDXG 0.07
- IOVA 0.03
- Stochastic Oscillator
- MDXG 39.50
- IOVA 22.67
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.